A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

(2011) Adrian M. Di Bisceglie et al.   HEPATOLOGY

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection

(2010) W. Alazawi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Natural course of treated and untreated chronic HCV infection: results of the nationwideHepnet.Greececohort study

(2009) E. K. MANESIS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C

(2009) Marc G. Ghany et al.   GASTROENTEROLOGY

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

The history of the “natural history” of hepatitis C (1968-2009)

(2009) Leonard B. Seeff   LIVER INTERNATIONAL

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

(2008) Adrian M. Di Bisceglie et al.   NEW ENGLAND JOURNAL OF MEDICINE